Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F13%3A10190865" target="_blank" >RIV/00216208:11310/13:10190865 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/13:10190865 RIV/00216305:26620/13:PU104579 RIV/00064203:_____/13:10190865
Result on the web
<a href="http://dx.doi.org/10.3390/ijms140713391" target="_blank" >http://dx.doi.org/10.3390/ijms140713391</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/ijms140713391" target="_blank" >10.3390/ijms140713391</a>

Result language
angličtina
Original language name
Apoferritin Modified Magnetic Particles as Doxorubicin Carriers for Anticancer Drug Delivery
Original language description
Magnetic particle mediated transport in combination with nanomaterial based drug carrier has a great potential for targeted cancer therapy. In this study, doxorubicin encapsulation into the apoferritin and its conjugation with magnetic particles was investigated by capillary electrophoresis with laser-induced fluorescence detection (CE-LIF). The quantification of encapsulated doxorubicin was performed by fluorescence spectroscopy and compared to CE-LIF. Moreover, the significant enhancement of the doxorubicin signal was observed by addition of methanol into the sample solution.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)